Renal cell carcinoma 2008: Histopathology, molecular genetics and new therapeutic options;Nierenzellkarzinom 2008: Histopathologie, molekulargenetik und neue therapien

Pathologe

Volumn 29, Issue 5, 2008, Pages 354-363

  Hammerschmied, C G ^a   Walter, B ^b   Hartmann, A ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b CARITAS KRANKENHAUS ST JOSEF   (Germany)

Author keywords

Histopathology; Kinase inhibitors; Molecular genetics; Prediction; Renal cell carcinoma

Indexed keywords

ALPHA INTERFERON; BEVACIZUMAB; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INTERLEUKIN 2; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A; SORAFENIB; SUNITINIB; TEMSIROLIMUS;

ARTICLE; CANCER CLASSIFICATION; CHROMOSOME ABERRATION; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DELETION; GENE TRANSLOCATION; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; KARYOTYPING; KIDNEY CARCINOMA; MOLECULAR GENETICS; NEPHRECTOMY; NEUTROPHIL CHEMOTAXIS; TUMOR BIOPSY; WORLD HEALTH ORGANIZATION;

ADENOMA; ADENOMA, OXYPHILIC; ANTINEOPLASTIC AGENTS; CARCINOMA, RENAL CELL; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 3; CHROMOSOMES, HUMAN, PAIR 5; CHROMOSOMES, HUMAN, PAIR 6; CHROMOSOMES, HUMAN, X; DIAGNOSIS, DIFFERENTIAL; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY NEOPLASMS; TRANSLOCATION, GENETIC;

EID: 51349086688     PISSN: 01728113     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00292-008-1011-5     Document Type: Article

References (43)

1. Ljungberg 2007 Eur Urol 51 1502
2. Nelson 2007 Cancer Treat Rev 33 299
3. Eble JN, Sauter G, Epstein JI et al. (eds) (2004) Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs. IARC Press, Lyon
4. Fuhrmann 1982 Am J Surg Pathol 6 655
5. Peruzzi 2006 Clin Cancer Res 12 3657
6. Argani 2007 Am J Surg Pathol 31 1149
7. Wunderlich 2005 J Urol 174 44
8. Sanjmyatav 2005 J Urol 174 731
9. Negrier 1998 N Engl J Med 338 1272
10. Coppin 2005 Cochrane Database Syst Rev CD001425
11. McDermott 2005 J Clin Oncol 23 133
12. Motzer 2000 J Clin Oncol 18 1928
13. Negrier 2007 Cancer 110 2468
14. Escudier 1999 J Clin Oncol 17 2039
15. Costa 2007 Oncologist 12 1404
16. Bergers 2003 J Clin Invest 111 1287
17. Erber 2004 FASEB J 18 338
18. Mendel 2003 Clin Cancer Res 9 327
19. Abrams 2003 Mol Cancer Ther 2 471
20. O 2003 Blood 101 3597
21. Oudard 2007 Ann Oncol 18 Suppl 10 x25
22. Motzer 2006 J Clin Oncol 24 16
23. Motzer 2006 JAMA 295 2516
24. Motzer 2007 N Engl J Med 356 115
25. Escudier 2007 N Engl J Med 356 125
26. Ratain 2006 J Clin Oncol 24 2505
27. Patel 2006 Br J Cancer 94 614
28. Atkins 2004 J Clin Oncol 22 909
29. Hudes 2007 N Engl J Med 356 2271
30. Presta 1997 Cancer Res 57 4593
31. Yang 2004 Clin Cancer Res 10 6367S
32. Escudier 2007 Lancet 370 2103
33. Ronnen 2006 Cancer 107 2617
34. Motzer 2002 J Clin Oncol 20 2376
35. Sosman 2007 Clin Cancer Res 13 764s
36. Lam 2007 Clin Cancer Res 13 703s
37. Junker 2007 European Urology Supplements 6 611
38. Sobin LH, Wittekind C (eds) (2002) TNM Classification of Malignant Tumours. John Wiley & Sons, Hoboken, New Jersey
39. Delahunt 2007 Pathology 39 459
40. Kirkali 2007 Eur Urol 51 1194
41. Takahashi 2006 J Med Invest 53 9
42. Atkins 2005 Clin Cancer Res 11 3714
43. Junker 2006 Urologe A 45 305